Relates to coverage for treatments to slow the progression of Alzheimer's disease and related dementias

Summary

The bill forces all comprehensive medical insurance policies in New York—including individual, group, and corporate plans—to pay for medically necessary diagnostic tests and FDA‑approved drugs that slow Alzheimer’s disease and related dementias, as prescribed by a licensed doctor. It also bans insurers from imposing step‑therapy requirements on those treatments. This expands access for patients and families while obligating insurers to adjust their coverage rules.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share